Core Viewpoint - The company reported a decline in revenue and net profit for 2024, with significant challenges in its membrane business, but anticipates potential recovery in 2025 due to market expansion and cost optimization efforts [1][2][3]. Financial Performance - In 2024, the company achieved revenue of 10.164 billion, a year-on-year decrease of 15.6%, and a net profit attributable to shareholders of -0.556 billion [1]. - For Q4 2024, revenue was 2.699 billion, down 8.47% year-on-year but up 0.65% quarter-on-quarter, with a net profit of -1.0 billion [1]. Business Segment Analysis - The company shipped 8.825 billion square meters of lithium membranes in 2024, a year-on-year increase of 42.33%, driven by capacity release and market expansion [2]. - Revenue from membrane business was 8.82 billion, with a significant drop in average selling price and a gross margin of 7.7%, down substantially from previous levels [2]. - The gross margin for lithium battery membranes was 7.39%, reflecting a decline of 32.44 percentage points, primarily due to inventory costs [2]. Future Outlook - The company expects Q4 2024 shipments to exceed expectations due to increased inventory sales, despite pressure on profitability from declining membrane prices and additional costs [3]. - For Q1 2025, shipments are projected to continue growing year-on-year, supported by negotiations with downstream customers and a significant impairment charge taken in Q4 2024 [3]. - The company aims to enhance profitability through product mix optimization, cost reduction, and recovery in ancillary business profits, reinforcing its competitive position in the market [3].
恩捷股份(002812):存货减值&费用拖累盈利 轻装上阵静待拐点